Raymond James Financial Services Advisors’s Clover Health Investments CLOV Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,693	Closed	-$79K	–	3334
2021 Q3	$79K	Buy	+10,693	New	+$91.5K	﹤0.01%	3144
2021 Q2	–	Sell	-20,461	Closed	-$155K	–	3320
2021 Q1	$155K	Sell	20,461 -27,656	-57%	-$312K	﹤0.01%	2964
2020 Q4	$807K	Buy	+48,117	New	+$536K	﹤0.01%	1841

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCP

Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Raymond James Financial Services Advisors's CLOV Position: Q4 2021 in Review

Raymond James Financial Services Advisors sold out of Clover Health Investments (CLOV) in Q4 2021, closing a stake of 10,693 shares — an estimated $79K sold.

Raymond James Financial Services Advisors first reported a position in CLOV in Q4 2020 and held it in 3 quarters. The position peaked at $807K in Q4 2020. 161 funds tracked by Wall St. Rank hold CLOV as of Q4 2021.

Raymond James Financial Services Advisors reported no remaining Clover Health Investments position as of Q4 2021 after selling out during the quarter.
Raymond James Financial Services Advisors sold 10,693 Clover Health Investments shares in Q4 2021, an estimated $79K.
Raymond James Financial Services Advisors first reported a position in Clover Health Investments in Q4 2020 and held it in 3 quarters.
Raymond James Financial Services Advisors's Clover Health Investments position peaked at $807K in Q4 2020.
161 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.